1.Histocompatibility and imprinting status of parthenogenetic embryonic stem cells.
Yuan XUE ; Zhiyan SHAN ; Zhong ZHENG ; Lei LEI
Journal of Biomedical Engineering 2010;27(5):1158-1161
The parthenogenetic embryonic stem cells (pESCs) derived from parthenogenetic embryos have the totipotency and proliferation capacity similar to those of the fertilized embryonic stem cells (fESCs). Therefore, the establishment of pESCs line avoids destroy of embryo and kence may make pESCs less concerns with political and ethical issues. These cells are characterized by their histocompatibility with the oocyte donor and therefore is more suitable for cell and tissue replacement therapy. In addition, because of the typical imprinting status, pESCs also provide a valuable in vitro model system for studying the molecular mechanisms in genomic imprinting.
Animals
;
Embryonic Stem Cells
;
cytology
;
Female
;
Gene Expression Profiling
;
methods
;
Gene Expression Regulation, Developmental
;
genetics
;
physiology
;
Genomic Imprinting
;
Histocompatibility
;
Parthenogenesis
;
genetics
;
physiology
;
Pluripotent Stem Cells
;
cytology
2.Transgenic mouse fetus generated from embryonic stem cells by tetraploid embryo complementation
Yanning XU ; Na GUAN ; Zhiyan SHAN ; Jingling SHEN ; Lianhong JIN ; Lei LEI
Acta Anatomica Sinica 2009;40(6):943-947
Objective To use tetraploid embryo complementation combined with gene transfer to produce genetically modified embryonic stem cells (EsCs) clones. Methods In this study, EGFP was introduced into ESCs by electroporation, and transfected positive cells were selected by G418 resistance. The tetraploid embryos were obtained from diploid blastomere electrofusion which preformed at 2-cell stage. Afterwards, 19-21 EGFP-ESCs were inserted into each tetraploid blastocyst cavity by piezo drilled microinjection,then the injected blastocysts were transferred into the uterus of pseudo-pregnancy at 2.5-day or the oviduct of 0.5-day female mice. Results The transfected ESCs maintained normal karyotype even after long-term passage (2n=40). The rate of fusion was 95.07%, and the developmental rate of tetraploid blastocyst was 95%.Totally 410 injected blastocysts were obtained. Unfortunately, we have not got any vital offsprings, except 151 implantation sites (pseudo-pregnancy 2.5 days:29.41%;the oviduct of half one day:64.37%). Furthermore, scattered EGFP expressions in transgenic fetus were observed under invert fluorescent microscope. Conclusion The transfected ESCs were observed in transgenic fetus, and the implantation rate in oviduct was higher than that in uterine.

Result Analysis
Print
Save
E-mail